[HTML] mdpi.com

[HTML][HTML] The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): which are the involved players?

G Lamberti, M Sisi, E Andrini, A Palladini, F Giunchi… - Cancers, 2020 - mdpi.com
Simple Summary Immunotherapy against PD-1/PD-L1 dramatically improved outcomes in
non-small cell lung cancer patients. These treatments are more effective the higher the …
被引用次数：53 相关文章

The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

G Lamberti, M Sisi, E Andrini, A Palladini… - …, 2020 - search.ebscohost.com
Abstract Simple Summary: Immunotherapy against PD-1/PD-L1 dramatically improved
outcomes in non-small cell lung cancer patients. These treatments are more effective the …

The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

G Lamberti, M Sisi, E Andrini, A Palladini… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Treatment with inhibition of programmed cell death 1 (PD-1) or its ligand (PD-L1) improves
survival in advanced non-small-cell lung cancer (NSCLC). Nevertheless, only a subset of …

The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

G Lamberti, M Sisi, E Andrini, A Palladini, F Giunchi… - Cancers, 2020 - go.gale.com
Immunotherapy against PD-1/PD-L1 dramatically improved outcomes in non-small cell lung
cancer patients. These treatments are more effective the higher the expression of PD-L1 on …
[HTML] nih.gov

[HTML][HTML] The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

G Lamberti, M Sisi, E Andrini, A Palladini, F Giunchi… - Cancers, 2020 - ncbi.nlm.nih.gov
Abstract Treatment with inhibition of programmed cell death 1 (PD-1) or its ligand (PD-L1)
improves survival in advanced non-small-cell lung cancer (NSCLC). Nevertheless, only a …
[PDF] semanticscholar.org

[PDF][PDF] The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

G Lamberti, M Sisi, E Andrini, A Palladini, F Giunchi… - pdfs.semanticscholar.org
Treatment with inhibition of programmed cell death 1 (PD-1) or its ligand (PD-L1) improves
survival in advanced non-small-cell lung cancer (NSCLC). Nevertheless, only a subset of …

The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

G Lamberti, M Sisi, E Andrini, A Palladini, F Giunchi… - Cancers, 2020 - europepmc.org
Abstract Treatment with inhibition of programmed cell death 1 (PD-1) or its ligand (PD-L1)
improves survival in advanced non-small-cell lung cancer (NSCLC). Nevertheless, only a …
[PDF] academia.edu

[PDF][PDF] The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?

G Lamberti, M Sisi, E Andrini, A Palladini, F Giunchi… - academia.edu
Treatment with inhibition of programmed cell death 1 (PD-1) or its ligand (PD-L1) improves
survival in advanced non-small-cell lung cancer (NSCLC). Nevertheless, only a subset of …

The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players?

G Lamberti, M Sisi, E Andrini, A Palladini, F Giunchi… - CANCERS, 2020 - cris.unibo.it
Abstract Treatment with inhibition of programmed cell death 1 (PD-1) or its ligand (PD-L1)
improves survival in advanced non-small-cell lung cancer (NSCLC). Nevertheless, only a …